Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled salbutamol versus placebo for neonatal transient tachypnea
IRCT201711139014N201Phase 2Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in transient tachypnea of the newborn (TTN) comparing Inhaled salbutamol with Placebo inhaler (2 arms). Started Nov 2017; status: completed.
02
Drugs
salbutamol
03
Conditions
transient tachypnea of the newborn (TTN)
Beyond the preview
Go deeper on IRCT201711139014N201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201711139014N201.